Novel molecular orbital interaction stabilizes cathode materials for lithium-ion batteries
Genesis Electrified GV70 makes North American debut

Solvay and Orbia to create JV to supply PVDF to battery market; largest capacity in N America

Solvay and Orbia have entered into a joint venture framework agreement to create a partnership for the production of suspension-grade polyvinylidene fluoride (PVDF), creating the largest capacity in North America.

The total investment is estimated to be around $850 million, and is expected to be funded in part by a grant awarded by the US Department of Energy of $178 million to Solvay to build a facility in Augusta, Georgia. Solvay and Orbia intend to use two production sites, one for raw materials and the other for finished product, located in the southeastern United States. Both plants are expected to be fully operational by 2026.

With more than half of US car sales projected to be electric by 2030, demand for lithium-ion batteries and PVDF, a thermoplastic fluoropolymer used as a lithium-ion binder and separator coating, is soaring. The Solvay-Orbia joint venture would fill a significant supply gap and will build upon favorable regulatory conditions promoting regional production and material security.

Solvay, a global leader in PVDF, brings process technology and global market know-how to this venture. With a vertically-integrated value chain and material holdings, Orbia’s Fluorinated Solutions business Koura and Polymer Solutions business Vestolit will supply hydrofluoric acid, vinyl chloride monomer (VCM) and chlorine respectively.

In combination, Solvay’s Solef PVDF innovations and Orbia’s raw material assets and production expertise will enable delivery of PVDF that optimizes energy storage efficiency by increasing battery energy density, safety and power.

A79b47f83de4dc3edaf4f14152ea9c13

Commencement of the joint venture is subject to finalizing and entering into definitive agreements between the parties and satisfaction of customary conditions, including obtaining regulatory approvals.

Comments

The comments to this entry are closed.